Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stevanato Group S.p.A (STVN) Return on Capital Employed (2021 - 2025)

Stevanato Group S.p.A (STVN) reported Return on Capital Employed of 9.99% for Q4 2025, up 106.0% year-over-year from 4.85% in Q4 2024, and up 11.87% on a QoQ basis from 8.93% in Q4 2024.

Stevanato Group S.p.A (STVN) has 5 years of Return on Capital Employed data on file, last reported at 9.99% in Q4 2025.

  • Quarterly Return on Capital Employed rose 106.0% year-over-year to 9.99% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 9.99% (up 106.0% YoY) and the FY2025 annual result came in at 11.01%, up 170.0% from the prior year.
  • Return on Capital Employed grew to 9.99% in Q4 2025 per STVN's latest filing, from 8.93% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 18.07% in Q3 2021 and bottomed at 8.93% in Q4 2024.
  • The 5-year median for Return on Capital Employed is 14.76% (2021), against an average of 13.89%.
  • The widest annual swing landed in 2022, when Return on Capital Employed soared 139 bps; it then tumbled 512 bps in 2024.
  • Tracing STVN's Return on Capital Employed over 5 years: stood at 15.47% in 2021, then climbed by 9 bps to 16.86% in 2022, then dropped by 17 bps to 14.05% in 2023, then sank by 36 bps to 8.93% in 2024, then grew by 12 bps to 9.99% in 2025.
  • Per Business Quant, the three latest STVN Return on Capital Employed figures stand at 9.99% (Q4 2025), 8.93% (Q4 2024), and 14.05% (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 17.54%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 5.02%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 25.95%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 18.63%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 19.44%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 6.60%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 12.74%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 13.02%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 12.04%
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 9.99%
Dec 31, 2024 8.93%
Dec 31, 2023 14.05%
Dec 31, 2022 16.86%
Dec 31, 2021 15.47%
Sep 30, 2021 18.07%